指南与共识心血管

心室-动脉耦联在心脏病与心力衰竭中的作用:评估、临床意义与治疗干预——欧洲心脏病学会主动脉与外周血管疾病工作组、欧洲心血管影像协会与心力衰竭协会共识文件

The role of ventricular-arterial coupling in cardiac disease and heart failure: assessment, clinical implications and therapeutic interventions. A consensus document of the European Society of Cardiology Working Group on Aorta & Peripheral Vascular Diseases, European Association of Cardiovascular Imaging, and Heart Failure Association.
指南 / 共识 · Eur J Heart Fail · 2019-03-12

该共识文件阐述了心室-动脉耦联(VAC)的病理生理、评估方法及在心脏病和心力衰竭中的临床意义。传统VAC以动脉弹性(Ea)与心室收缩末期弹性(Ees)比值评估,疾病进展时Ea和Ees可同时异常而比值接近正常,故建议测量各组分或更敏感指标如整体纵向应变和脉搏波速度。在瓣膜病中系统动脉顺应性和瓣膜-动脉阻抗具有诊断和预后价值,改善VAC的治疗可能延缓心衰发生并可能改善预后。

要点

  • VAC评估具有独立诊断和预后价值,可用于细化风险分层和监测治疗干预。
  • 传统Ea/Ees比值在疾病进展时可能因两者同时异常而接近正常,需测量各组分或采用更敏感指标。
  • 瓣膜病中系统动脉顺应性和瓣膜-动脉阻抗有明确诊断和预后价值,可监测瓣膜置换对血管和心功能的影响。

核心结论

  • VAC在心脏和主动脉力学生理及心脏病病理生理中起重要作用,其评估具有独立诊断和预后价值,可用于细化风险分层和监测治疗干预。
  • 传统VAC通过无创测量动脉弹性(Ea)与心室收缩末期弹性(Ees)比值评估,但疾病进展时Ea和Ees可同时异常而Ea/Ees比值接近正常,因此测量比值各组分或更敏感的心肌(如整体纵向应变)和动脉功能(如脉搏波速度)标志物可能更好地表征VAC。
  • 在瓣膜性心脏病中,系统动脉顺应性和瓣膜-动脉阻抗具有已确立的诊断和预后价值,并可监测瓣膜置换对血管和心脏功能的影响。
  • 通过改善VAC及其一个或两个组分来指导治疗,可能延缓心力衰竭的发生并可能改善心力衰竭的预后。

研究设计与样本

  • 欧洲心脏病学会主动脉与外周血管疾病工作组、欧洲心血管影像协会与心力衰竭协会共识文件。
  • 文件描述了VAC的病理生理、评估方法以及在心脏病和心力衰竭中的临床意义,并聚焦于可能改善VAC从而改变预后的干预措施。

诊断标准与关键数值

  • 传统VAC评估采用无创测量的动脉弹性(Ea)与心室收缩末期弹性(Ees)比值。
  • 疾病进展时Ea和Ees可同时异常,Ea/Ees比值可能接近正常值。
  • 测量Ea/Ees比值各组分或更敏感标志物(如整体纵向应变、脉搏波速度)可能更好地表征VAC。
  • 瓣膜性心脏病中系统动脉顺应性和瓣膜-动脉阻抗具有已确立的诊断和预后价值。

临床应用与阅片要点

  • VAC评估可用于细化风险分层和监测治疗干预。
  • 在瓣膜性心脏病中,系统动脉顺应性和瓣膜-动脉阻抗可用于诊断、预后评估以及监测瓣膜置换对血管和心脏功能的影响。
  • 通过改善VAC及其组分的治疗可能延缓心力衰竭发生并可能改善心力衰竭预后。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Ventricular-arterial coupling (VAC) plays a major role in the physiology of cardiac and aortic mechanics, as well as in the pathophysiology of cardiac disease. VAC assessment possesses independent diagnostic and prognostic value and may be used to refine riskstratification and monitor therapeutic interventions. Traditionally, VAC is assessed by the non-invasive measurement of the ratio of arterial (Ea) to ventricular end-systolic elastance (Ees). With disease progression, both Ea and Ees may become abnormal and the Ea/Ees ratio may approximate its normal values. Therefore, the measurement of each component of this ratio or of novel more sensitive markers of myocardial (e.g. global longitudinal strain) and arterial function (e.g. pulse wave velocity) may better characterize VAC. In valvular heart disease, systemic arterial compliance and valvulo-arterial impedance have an established diagnostic and prognostic value and may monitor the effects of valve replacement on vascular and cardiac function. Treatment guided to improve VAC through improvement of both or each one of its components may delay incidence of heart failure and possibly improve prognosis in heart failure. In this consensus document, we describe the pathophysiology, the methods of assessment as well as the clinical implications of VAC in cardiac diseases and heart failure. Finally, we focus on interventions that may improve VAC and thus modify prognosis.

来源:Eur J Heart Fail,查看原文。版权归原作者所有。

引用

  1. Ikonomidis I, Aboyans V, Blacher J, et al. The role of ventricular-arterial coupling in cardiac disease and heart failure: assessment, clinical implications and therapeutic interventions. A consensus document of the European Society of Cardiology Working Group on Aorta & Peripheral Vascular Diseases, European Association of Cardiovascular Imaging, and Heart Failure Association. Eur J Heart Fail. 2019. PMID: 30859669. doi:10.1002/ejhf.1436

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。